A lenient approach to heart rate control in atrial fibrillation (AF) is just as effective as the strict approach generally recommended in guidelines, Dutch researchers have found.
A Quebec study has shown many myocardial infarction patients are receiving reperfusion therapy outside recommended time windows, and this is putting them at increased risk of dying within 30 days.
